PreludeDx

PreludeDx is a leader in personalized breast cancer diagnostics, offering precision tools that empower patients and physicians worldwide to make more informed, shared treatment decisions. The company offers DCISionRT for Ductal Carcinoma In Situ (DCIS) and AidaBreast for early-stage invasive breast cancer, which provide genomic insights into a patient’s unique tumor biology.